Workshop on new medicines for treatment of drug-resistant tuberculosis held in Copenhagen

The regional Green Light Committee for the WHO European Region (rGLC/Europe) conducted a workshop on the “Introduction of new medicines for the treatment of drug-resistant tuberculosis in the WHO European Region” on 25–26 July 2017, followed by a meeting on 27 July, in Copenhagen, Denmark.

The overall objectives of the 3 days were to exchange experiences and update rGLC/Europe members and consultants on the introduction of new drugs, new treatment regimens and current WHO global and regional policies and initiatives.

Participants included:

  • members of the rGLC/Europe;
  • representatives from the Global Drug Facility, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the TB Europe Coalition, and the United States Agency for International Development (USAID);
  • country representatives from Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Ukraine and Uzbekistan;
  • staff members from the WHO Global TB Programme and from the WHO/Europe Joint Tuberculosis, HIV and Hepatitis Programme.

One of the key outcomes of the sessions was a set of recommendations for action put forward to WHO and partners.